Diagnostic value of integrin α3, β4, and β5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma

Cancer

Volumn 112, Issue 6, 2008, Pages 1272-1281

  Kurokawa, Akira ^a   Nagata, Masaki ^a   Kitamura, Nobutaka ^a   Noman, Arhab A ^a   Ohnishi, Makoto ^b   Ohyama, Tokio ^b   Kobayashi, Takanori ^a   Shingaki, Susumu ^a   Takagi, Ritsuo ^a  

^a NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^b NAGAOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Distant metastasis; Integrin 3; Integrin 4; Integrin 5; Lymph node metastasis

Indexed keywords

ALPHA3 INTEGRIN; BETA4 INTEGRIN; BETA5 INTEGRIN; GLOBULIN; PAXILLIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CERVICAL LYMPH NODE; CYTOSKELETON; DESMOSOME; DIAGNOSTIC VALUE; DISEASE COURSE; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; HOUSEKEEPING GENE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANK SUM TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAMPLE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TONGUE CARCINOMA; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DESMOPLAKINS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; INTEGRIN ALPHA3; INTEGRIN BETA CHAINS; INTEGRIN BETA4; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PAXILLIN; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TONGUE NEOPLASMS;

EID: 41149156919     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23295     Document Type: Article

References (39)

1. Sessions DG, Lenox J, Spector GJ, Chao C, Chaudry OA. Analysis of treatment results for base of tongue cancer. Laryngoscope. 2003;113:1252-1261.
2. Mitchell R, Crighton LE. The management of patients with carcinoma of the tongue. Br J Oral Maxillofac Surg. 1993;31:304-308.
3. Kurokawa H, Zhang M, Matsumoto S, et al. The high prognostic value of the histologic grade at the deep invasive front of tongue squamous cell carcinoma. J Oral Pathol Med. 2005;34:329-333.
4. Okamoto M, Nishimine M, Kishi M, et al. Prediction of delayed neck metastasis in patients with stage I/II squamous cell carcinoma of the tongue. J Oral Pathol Med. 2002;31:227-233.
5. Habel LA, Shak S, Jacobs MK, et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res. 2006;8:R25-R25.
6. Paik S, Tang G, Shak S, et al. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol. 2006;24:3726-3734.
7. Nagata M, Fujita H, Ida H, et al. Identification of potential biomarkers of lymph node metastasis in oral squamous cell carcinoma by cDNA microarray analysis. Int J Cancer. 2003;106:683-689.
8. Lim SC, Zhang S, Ishii G, et al. Predictive markers for late cervical metastasis in stage I and II invasive squamous cell carcinoma of the oral tongue. Clin Cancer Res. 2004;10(1 pt 1):166-172.
9. Danen EH, Sonnenberg A. Integrins in regulation of tissue development and function. J Pathol. 2003;200:471-480.
10. Plow EF, Haas TA, Zhang L, Loftus J, Smith JW. Ligand binding to integrins. J Biol Chem. 2000;275:21785-21788.
11. Giancotti FG. Complexity and specificity of integrin signalling. Nat Cell Biol. 2000;2:E13-E14.
12. Calderwood DA, Shattil SJ, Ginsberg MH. Integrins and actin filaments: reciprocal regulation of cell adhesion and signaling. J Biol Chem. 2000;275:22607-22610.
13. Giancotti FG, Ruoslahti E. Integrin signaling. Science. 1999;285:1028-1032.
14. Stupack DG, Cheresh DA. Get a ligand, get a life: integrins, signaling and cell survival. J Cell Sci. 2002;115(pt 19):3729-3738.
15. Eriksen JG, Steiniche T, Sogaard H, Overgaard J. Expression of integrins and E-cadherin in squamous cell carcinomas of the head and neck. APMIS. 2004;112:560-568.
16. Varma RR, Hector SM, Clark K, Greco WR, Hawthorn L, Pendyala L. Gene expression profiling of a clonal isolate of oxaliplatin-resistant ovarian carcinoma cell line A2780/C10. Oncol Rep. 2005;14:925-932.
17. Dedhar S, Saulnier R, Nagle R, Overall CM. Specific alterations in the expression of alpha 3 beta 1 and alpha 6 beta 4 integrins in highly invasive and metastatic variants of human prostate carcinoma cells selected by in vitro invasion through reconstituted basement membrane. Clin Exp Metastasis. 1993;11:391-400.
18. Leavesley DI, Ferguson GD, Wayner EA, Cheresh DA. Requirement of the integrin beta 3 subunit for carcinoma cell spreading or migration on vitronectin and fibrinogen. J Cell Biol. 1992;117:1101-1107.
19. Reynolds LE, Wyder L, Lively JC, et al. Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins. Nat Med. 2002;8:27-34.
20. Bagutti C, Speight PM, Watt FM. Comparison of integrin, Cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol. 1998;186:8-16.
21. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratsuka H. Mode of invasion, bleomycin sensitivity, and clinical course in squamous cell carcinoma of the oral cavity. Cancer. 1983;51:2175-2180.
22. DiPersio CM, Hodivala-Dilke KM, Jaenisch R, Kreidberg JA, Hynes RO. Alpha3beta1 integrin is required for normal development of the epidermal basement membrane. J Cell Biol. 1997;137:729-742.
23. Gonzales M, Haan K, Baker SE, et al. A cell signal pathway involving laminin-5, alpha3beta1 integrin, and mitogen-activated protein kinase can regulate epithelial cell proliferation. Mol Biol Cell. 1999;10:259-270.
24. Miyamoto S, Maruyama A, Okugawa K, et al. Loss of motility-related protein 1 (MRP1/CD9) and integrin alpha3 expression in endometrial cancers. Cancer. 2001;92:542-548.
25. Manohar A, Shome SG, Lamar J, et al. Alpha 3 beta 1 integrin promotes keratinocyte cell survival through activation of a MEK/ERK signaling pathway. J Cell Sci. 2004;117(pt 18):4043-4054.
26. Wang H, Fu W, Im JH, et al. Tumor cell alpha3beta1 integrin and vascular laminin-5 mediate pulmonary arrest and metastasis. J Cell Biol. 2004;164:935-941.
27. Hashida H, Takabayashi A, Tokuhara T, et al. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82. Int J Cancer. 2002;97:518-525.
28. Ura H, Denno R, Hirata K, Yamaguchi K, Yasoshima T. Separate functions of alpha2beta1 and alpha3beta1 integrins in the metastatic process of human gastric carcinoma. Surg Today. 1998;28:1001-1006.
29. Nievers MG, Schaapveld RQ, Sonnenberg A. Biology and function of hemidesmosomes. Matrix Biol. 1999;18:5-17.
30. Rabinovitz I, Mercurio AM. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures. J Cell Biol. 1997;139:1873-1884.
31. Grossman HB, Lee C, Bromberg J, Liebert M. Expression of the alpha6beta4 integrin provides prognostic information in bladder cancer. Oncol Rep. 2000;7:13-16.
32. Tagliabue E, Ghirelli C, Squicciarini P, Aiello P, Colnaghi MI, Menard S. Prognostic value of alpha 6 beta 4 integrin expression in breast carcinomas is affected by laminin production from tumor cells. Clin Cancer Res. 1998;4:407-410.
33. Gleason B, Adley B, Rao MS, Diaz LK. Immunohistochemical detection of the beta4 integrin subunit in pancreatic adenocarcinoma. J Histochem Cytochem. 2005;53:799-801.
34. Lipscomb EA, Simpson KJ, Lyle SR, Ring JE, Dugan AS, Mercurio AM. The alpha6beta4 integrin maintains the survival of human breast carcinoma cells in vivo. Cancer Res. 2005;65:10970-10976.
35. Zahir N, Lakins JN, Russell A, et al. Autocrine laminin-5 ligates alpha6beta4 integrin and activates RAC and NFkappaB to mediate anchorage-independent survival of mammary tumors. J Cell Biol. 2003;163:1397-1407.
36. Janes SM, Watt FM. Switch from alphavbeta5 to alphavbeta6 integrin expression protects squamous cell carcinomas from anoikis. J Cell Biol. 2004;166:419-431.
37. Suzuki T, Higgins PJ, Crawford DR. Control selection for RNA quantitation. Biotechniques. 2000;29:332-337.
38. Uematsu J, Nishizawa Y, Hirako Y, et al. Both type-I hemidesmosomes and adherens-type junctions contribute to the cell-substratum adhesion system in myoepithelial cells. Eur J Cell Biol.84(2-3):407-415, 2005.
39. Mathur M, Goodwin L, Cowin P. Interactions of the cytoplasmic domain of the desmosomal Cadherin Dsg1 with plakoglobin. J Biol Chem. 1994;269:14075-14080.